Mesoblast Ltd Files 6-K with ASX Announcement
Ticker: MEOBF · Form: 6-K · Filed: Oct 1, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing, press-release
Related Tickers: MESO
TL;DR
MESO filed a 6-K with an ASX announcement on Sept 30. Stay tuned.
AI Summary
On September 30, 2024, Mesoblast Limited announced a new release filed with the Australian Securities Exchange. The company is a foreign private issuer incorporated in Australia and its principal executive offices are located in Melbourne. Silviu Itescu is the Chief Executive Officer and Executive Director.
Why It Matters
This filing indicates ongoing corporate communications and regulatory updates from Mesoblast Limited, which could impact investors' understanding of the company's current activities.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a press release and does not contain significant new financial or operational information that would immediately alter risk.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- September 30, 2024 (date) — Date of ASX announcement filing
- Australian Securities Exchange (company) — Exchange where announcement was filed
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report a new release announcement filed by Mesoblast Limited with the Australian Securities Exchange on September 30, 2024.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
In which country is Mesoblast Limited incorporated?
Mesoblast Limited is incorporated in Australia.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is October 1, 2024.
What exhibit is incorporated into this Form 6-K?
Exhibit 99.1, which is the new release announcement filed with the Australian Securities Exchange, is incorporated into this Form 6-K.
Filing Stats: 254 words · 1 min read · ~1 pages · Grade level 14.6 · Accepted 2024-09-30 21:32:13
Filing Documents
- a2024-10x01convertiblenote.htm (6-K) — 21KB
- exhibit991.htm (EX-99.1) — 10KB
- exhibit992.htm (EX-99.2) — 2KB
- exhibit991001.jpg (GRAPHIC) — 240KB
- exhibit991002.jpg (GRAPHIC) — 313KB
- exhibit991003.jpg (GRAPHIC) — 83KB
- exhibit992001.jpg (GRAPHIC) — 74KB
- exhibit992002.jpg (GRAPHIC) — 104KB
- exhibit992003.jpg (GRAPHIC) — 135KB
- exhibit992004.jpg (GRAPHIC) — 158KB
- exhibit992005.jpg (GRAPHIC) — 93KB
- 0001345099-24-000068.txt ( ) — 1686KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated October 1, 2024 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated September 30, 2024. 99.2 Appendix 3B of Mesoblast Ltd, dated September 30, 2024.